Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing 99mTc Sestamibi SPECT/CT with 18F Fluorocholine PET/CT for locating Parathyroid Adenoma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Andrei Iagaru | Conditions: Parathyroid Adenoma | Phase 2, Phase 3 | Status: RECRUITING